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Background: A leptin-like immunoreactive substance has been found in chicken eggs and has been implicated in
serving as a maternal signal to program offspring growth and metabolism. In the present study, we investigated the
effects of in ovo leptin administration on hatch weight, serum and hepatic concentrations of metabolites and
hormones, as well as on the expression of genes involved in hepatic lipid metabolism and the predicted microRNAs
(miRNAs) targeting the affected genes. To this end we injected fertile eggs with either 0.5 μg of recombinant
murine leptin or vehicle (PBS) before incubation.
Results: Prenatally leptin-exposed chicks showed lower hatch weight, but higher liver weight relative to the body
weight, compared to the control group. In ovo leptin treatment increased the hepatic content and serum
concentration of leptin in newly hatched chickens. The hepatic contents of triglycerides (TG) and total cholesterol
(Tch) were decreased, whereas the serum levels of TG, Tch and apolipoprotein B (ApoB) were increased. The hepatic
mRNA expression of sterol regulator element binding protein 1 (SREBP-1c), SREBP-2, hydroxy-3-methylglutaryl coenzyme
A reductase (HMGCR) and cholesterol 7α-hydroxylase 1 (CYP7A1) was significantly up-regulated, as was the protein
content of both SREBP-1c and SREBP-2 in hepatic nuclear extracts of leptin-treated chickens. Moreover, out of 12
miRNAs targeting SREBP-1c and/or HMGCR, five were significantly up-regulated in liver of leptin-treated chicks,
including gga-miR-200b and gga-miR-429, which target both SREBP-1c and HMGCR.
Conclusions: These results suggest that leptin in ovo decreases hatch weight, and modifies hepatic leptin secretion
and lipid metabolism in newly hatched broiler chickens, possibly via microRNA-mediated gene regulation.
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Leptin is involved in the regulation of food intake and
energy balance in mammals [1,2]. Despite the current
controversy over the existence of a leptin gene in the
chicken genome [3], the existence of a leptin-like immu-
noreactive substance [4,5] and a functional leptin receptor
(LEPR) has been confirmed [6]. Furthermore, exogenous
murine or human leptin exerts similar effects on poultry
as it does on mammals [7,8].
Maternal leptin has been shown to program offspring
obesity in mammals [9]. Fetal or neonatal abnormal nutri-
tional environment induces leptin synthesis and secretion* Correspondence: zhao.ruqian@gmail.com
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medium, provided the original work is properfrom adipocytes, and affects adipocyte morphology and
metabolism, thus linking embryonic nutrition to adult
obesity [10]. Manipulating either maternal plasma leptin
or transplacental leptin transfer could impact the postnatal
regulation of leptin synthesis and secretion in the offspring
[11-13]. Previously, we have demonstrated the presence of
a leptin-like immunoreactive substance in the yolk and al-
bumen of chicken eggs [4]. Moreover, feeding hens with
low-protein [14] or cysteamine-supplemented diets [4]
affects leptin deposition in eggs, as well as early posthatch
growth and metabolism of chickens. In ovo administration
of leptin improved embryonic development and resulted
in higher body weight at hatching of Japanese quails [15].
These findings imply possible roles of maternal leptin
deposited in the egg in programming offspring growth and
metabolism in poultry.This is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any
ly cited.
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sue, and exerts direct effects on lipolysis and lipogenesis
of adipose tissue [2]. In birds, liver is the major source of
leptin [16] and the primary organ for lipogenesis [17].
Therefore, it is of interest whether in ovo administration
of leptin affects hepatic leptin synthesis and secretion, as
well as hepatic lipid homeostasis in newly hatched
chickens.
Hepatic lipid homeostasis is regulated by a family of
membrane-bound transcription factors, designated sterol
regulatory element binding proteins (SREBPs) [18].
SREBP-1c, the most abundant isoform of SREBP-1 in the
liver, preferentially enhances transcription of enzymes
required for fatty acid synthesis, including acetyl CoA
carboxylase (ACC), carnitine palmitoyltransferase I
(CPT-I) and fatty acid synthase (FAS), whereas SREBP-2
is more selective for activating genes involved in choles-
terol homeostasis, including HMG-CoA reductase
(HMGCR) and cholesterol 7α-hydroxylase 1 (CYP7A1)
[18]. Leptin has been shown to negatively regulate the
expression of SREBPs [2], HMGCR [19], CYP7A1 [19],
ACC and FAS [2], thus inhibiting lipogenesis in mamma-
lian species.
MicroRNAs (miRNAs) are small noncoding RNAs
with an average size of 22 nt. They bind to complemen-
tary sequences of target messenger RNA transcripts
(mRNAs), usually resulting in translational repression
and gene silencing [20]. A number of mammalian miR-
NAs that execute post-transcriptional regulation of genes
involved in lipid homeostasis have been identified
[21,22]. Recently, miR-33, which is located in the intron
of SREBPs, was reported to regulate cholesterol metabol-
ism [23,24]. Moreover, miRNAs have been shown to me-
diate the effects of leptin on adipocyte differentiation
[25] and adipogenesis [26] in mammals. However, it is
unknown whether the programming effects of maternal
leptin involve miRNA-mediated post-transcriptional
regulation. Relatively little is known about the function
of miRNAs in chickens. More than 50 miRNAs have
been identified in chicken liver [27-29], but only miR-33
has been experimentally verified to target the FAS gene
in chicken fibroblast cells [30]. A correlation study link-
ing the expression of miRNAs and their target genes, in
association with hepatic lipid homeostasis may shed light
on the potential functions of miRNAs in the chicken
liver.
Therefore, the present study aimed to investigate the
effects of in ovo leptin administration on hepatic leptin
synthesis and secretion, as well as on hepatic lipid
homeostasis in newly hatched chickens. The expression
of genes involved in hepatic lipid metabolism, such as
SREBPs and HMGCR, and of the predicted miRNAs tar-
geting the relevant genes was also determined to reveal
the possible mechanisms.Methods
Animals and experimental design
Fertile breeder eggs purchased from Sanhuang broiler
breeding farm (Wen’s group, Guangdong, China) were
randomly divided into two groups and injected with 0 μg
(Control, Con) or 0.5 μg (Leptin, Lep) of recombinant
murine leptin (498-OB-01 M, R&D, Minneapolis, MN,
USA) in 100 μL of phosphate buffered saline (PBS) be-
fore incubation. After injection, all eggs were incubated
in a forced draught incubator with automatic turning
every two hours at 37.5 ± 0.3°C and 50% to 60% humid-
ity. At hatching (D0), chicks from each group were
weighed and 12 chicks (6 males and 6 females) from
each group were euthanized to take blood and liver
samples. All tissue samples were snap frozen in liquid ni-
trogen and stored at -80°C. The experiments were under-
taken following the guidelines of the Animal Ethics
Committee of Nanjing Agricultural University, China.Measurement of lipid parameters
Total lipid content in homogenized liver samples was
extracted using a mixture of chloroform and methanol
(2:1 v/v) according to a previously reported method [31].
The hepatic contents and serum concentrations of trigly-
cerides (TG) and total cholesterol (TC) were determined
using commercial kits (GPO-PAP and CHOD-PAP) pur-
chased from Nanjing Jiancheng Biotechnology Institute
(NJBI, Nanjing, Jiangsu, China) following the manufac-
turer’s protocols.Tissue extraction and measurement of leptin and
apolipoprotein B
Frozen liver samples (approximately 200 mg) were
homogenized in 2 mL of ice-cold lysis buffer (50 mmol/L
Tris-HCl, pH 7.5, 0.2% Triton X-100 and protease in-
hibitor mixture) using a tissue grinder (Polytron
PT1200E, Brinkman Instruments, Littau, Switzerland).
The homogenate was then centrifuged at 5,000 × g for
20 min at 4°C to remove all insoluble material. The
supernatant was collected, and the protein concentration
was determined with a Bradford assay kit purchased
from NJBI.
Leptin in serum and liver extracts was measured with a
commercial multi-species RIA kit purchased from Beijing
North Institute of Biotechnology (Beijing, China). The
detection limit for leptin was 0.45 ng/mL. The intra- and
inter-assay coefficients of variation were 5% and 10%,
respectively. The commercial RIA kit was previously vali-
dated for measuring chicken samples [32]. Serum apolipo-
protein B (ApoB) was determined using a commercial kit
purchased from Biosino Biotechnology Company Ltd.
(Beijing, China).









β-actin NM 205518 300 F: 5′- tgcgtgacatcaaggagaag -3′
R: 5′- tgccagggtacattgtggta -3′
LEPR NM 204323 87 F: 5′- gcatctctgcatctcaggaaaga -3′
R: 5′- gcaggctacaaactaacagatcca -3′
SREBP-1c NM 204126 104 F: 5′- gcagaagagcaagtccctcaa -3′
R: 5′- tcggcatctccatcacctc -3′
SREBP-2 XM 416222 108 F: 5′- cccagaacagcaagcaagg -3′
R: 5′- gcgaggacaggaaagagagtg -3′
HMGCR AB 109635 137 F: 5’-ttggatagagggaagagggaag -3’
R: 5’- ccatagcagaacccaccaga-3’
CYP7A1 AB 109636 106 F:5’- cattctgttgccaggtgatgtt -3’
R:5’- gctctctctgtttcccgcttt -3’
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Nuclear and cytoplasmic protein was extracted from liver
samples using Nuclear Protein Extraction Kit (PR116,
Yuanpinghao Biotechnology Ltd., Beijing, China). Nuclear
protein extracts were used for detecting SREBP-1c and
SREBP-2, while cytoplasmic protein extracts were used for
determining HMGCR and CYP7A1 levels. Whole cell
lysates were prepared for quantitating leptin receptor
(LEPR) by western blot analysis.
After electrophoresis, proteins were transferred to
nitrocellulose membranes, which were then blocked with
5% fat-free milk or 3% BSA in Tween-Tris-buffer saline
(TBST) for 2 h at room temperature. After repeated
washing with TBST, the membranes were incubated with
monoclonal antibodies against LEPR (diluted 1:1,000; a
generous gift from Dr. Ohkubo, Faculty of Agriculture,
Kagawa University, Japan), SREBP-1c (MA1-38651,
Thermo, Waltham, MA, USA; diluted 1:200), SREBP-2
(ab30682, Abcam, UK; diluted 1:300), HMGCR (diluted
1:1,000; sc-33827, Santa Cruz, California, CA, USA) or
CYP7A1 (diluted 1:200; ab79847, Cambridge, Abcam),
followed by goat polyclonal horseradish peroxidase
conjugated secondary antibody to rabbit IgG (diluted
1:5,000; ab6721, Abcam) or mouse IgG (diluted 1:4,000;
GGHL-90P, Immunology Consultants Laboratory,
Newberg, OR, USA), as previously described [6].
Finally, the membranes were washed and the specific
signals were detected by chemiluminescence using the
LumiGlo substrate (Super Signal West Pico Trial Kit,
Pierce, Rockford, IL, USA). Enhanced chemiluminescence
(ECL) signals recorded on x-ray film were scanned and
analyzed with Kodak 1D Electrophoresis Documentation
and Analysis System 120 (Kodak Photo Film Co. Ltd.,
Rochester, NY, USA). The membranes were stripped and
reprobed with an antibody against β-actin (diluted 1:4,000;
ab8227, Abcam) or LAMINA/C (diluted 1:500; BS1446,
Bioworld Technology, Minneapolis, MN, USA), followed by
horseradish peroxidase conjugated secondary antibodies
(diluted 1:5,000; ab6721, Abcam). β-actin was used to
normalize the band density of LEPR, HMGCR and
CYP7A1, and LAMINA/C was used to normalize the band
density of SREBP-1c and SREBP-2. The hepatic contents of
LEPR, SREBP-1c, SREBP-2, HMGCR and CYP7A1 were
presented as the fold change relative to the average values
of the control group.
RNA extraction and mRNA quantification
Total RNA was extracted using TRIzol total RNA Kit
(Tiangen Biotech Co., Ltd., Beijing, China), and 2 μg of
total RNA were reverse-transcribed in a final volume of
25 μL with M-MLV reverse transcriptase (M1701,
Promega, Madison, WI, USA) in a Bio-Rad DNA Engine
Peltier Thermal Cycler PTC0200 (Bio-Rad, Hercules,
CA, USA). Real-time PCR was performed to quantitateLEPR, SREBP-1c/2, HMGCR and CYP7A1 mRNA with
Mx3000P (Stratagene, Santa Clara, CA, USA). The primers
were designed and synthesized by TaKaRa Biotechnology
Co., Ltd. (Dalian, Shandong, China; Table 1).Real-time PCR
Different controls were set to monitor the possible
contamination of genomic and environmental DNA both
at the stage of reverse transcription and PCR. A pooled
sample made by mixing an equal quantity of total RNA
from all samples was used for optimizing the PCR condi-
tions and tailoring the standard curves. Two microliters of
8-64-fold dilutions of each reverse transcription product
were used for PCR in a final volume of 25 μL. The PCR end
products were verified with the melting curves that showed
a single peak specific for the target gene.miRNA quantification
Total RNA isolated from liver was treated with RNase-free
DNase I (TaKaRa, Tokyo, Japan), and then polyadenylated
(2 μg) by poly(A) polymerase (Ambion, Austin, TX, USA)
at 37°C for 1 h in a 20 μL reaction mixture. After phenol-
chloroform extraction and isopropyl ethanol precipitation,
the RNA was dissolved and reverse-transcribed using a poly
(T) adapter [33].
qPCR was performed using SYBR Green Real-time
PCR Master Mix (TaKaRa) with a miRNA-specific forward
primer and a universal reverse primer complementary to
part of the poly(T) adapter sequence. Because no validated
reference gene was available for chicken miRNA, random
DNA oligonucleotides were added to the RNase-free
Dnase I-treated total RNA samples before polyadenylation,
as an exogenous reference, to normalize the expression
of miRNAs. The sequences for all the primers, poly(T)
Table 3 Effects of in ovo leptin administration on body
weight, liver weight and liver index (liver weight relative
to body weight) in newly hatched chicks
Parameters Control Leptin
Body weight (g) 36.34 ± 0.32 33.30 ± 0.65**
Liver weight (mg) 801.0 ± 22.0 801.7 ± 16.1
Liver index (%) 2.21 ± 0.06 2.42 ± 0.07*
Values are presented as means ± SEM. *P< 0.05, **P< 0.01 compared with
control, n = 12.
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in Table 2.
No 5′UTR sequence was available for the chicken
CYP7A1 gene, therefore we just predicted the miRNAs
targeting SREBP-1c, SREBP-2 and HMGCR with Targets-
can 5.1 (http://www.targetscan.org/) [34-36]. Five miR-
NAs were predicted to target SREBP-1c, while nine
miRNAs were predicted to target HMGCR. Only one
miRNA, gga-miR-138, was predicted to target SREBP-2.
However, we were unable to amplify specific gga-miR-
138 from the chicken hepatic samples; therefore we
excluded gga-miR-138 from the present study.Statistical analysis
The method of 2-ΔΔCt was used to analyze the real-time
PCR data expressed as the fold change relative to the
control group [37]. All data were presented as means ±
SEM. Statistical analyses were carried out with SPSS11.0
for windows (SPSS Inc., Chicago, IL, USA). The differ-
ences were tested with t-test for Independent-Samples. A
P value of less than 0.05 was considered significant.Results
Body weight and liver weight
As shown in Table 3, chicks that hatched from leptin-
treated eggs exhibited significantly lower hatch weight
(P= 0.000). No alterations were observed in the absolute
liver weights, but the liver weight relative to the body
weight, or the liver index, was significantly higher in the
leptin-treated group at hatching (P= 0.018).Table 2 Primer sequences for miRNAs used in the study
Names Primer sequences
gga-miR-15a F: 5′- TAGCAGCACATAATGGTTTGT -3′
gga-miR-15b F: 5’- TAGCAGCACATCATGGTTTGCA -3’
gga-miR-16 F:5’- TAGCAGCACGTAAATATTGGTG -3’
gga-miR-27b F:5’- TTCACAGTGGCTAAGTTCTGC -3’
gga-miR-99a F:5’- AACCCGTAGATCCGATCTTGTG -3’
gga-miR-100 F: 5′- AACCCGTAGATCCGAACTTGTG -3′
gga-miR-181a F: 5′- AACATTCAACGCTGTCGGTGAGT -3′
gga-miR-183 F: 5′- AACATTCATTGCTGTCGGTGGG -3′
gga-miR-200a F: 5′- TAACACTGTCTGGTAACGATGT -3′
gga-miR-200b F: 5′- TAATACTGCCTGGTAATGATGAT -3′
gga-miR-223 F: 5′- TGTCAGTTTGTCAAATACCCC -3′
gga-miR-429 F: 5′- TAATACTGTCTGGTAATGCCGT -3′
exogenous reference F: 5′- GTGACCCACGATGTGTATTCGC -3′
universal reverse primer F: 5′- TAGAGTGAGTGTAGCGAGCA -3′
poly(T) adapter F:5′- TAGAGTGAGTGTAGCGAGCACAGA
ATTAATACGACTCACTATAGG(T)16VN-3′Serum and hepatic contents of leptin and hepatic LEPR
expression
As shown in Table 4, in ovo administration of leptin signifi-
cantly increased the serum concentration (P=0.009) and
liver content (P=0.041) of leptin in newly hatched chicks.
Western blot analysis with a specific antibody against
chicken LEPR detected a band of approximately 180 kDa
in liver whole cell lysates (Figure 1A and B). In ovo leptin
injection did not affect either LEPR mRNA abundance
or LEPR protein content in the liver of newly hatched
chicks (Figure 1).
Lipid contents in serum and Liver
As shown in Table 4, the TG content in the liver was
greatly decreased (P= 0.053), whereas the TG concentra-
tion in the serum significantly increased (P= 0.037) in
leptin-treated chicks. The hepatic and serum contents of
Tch showed the same pattern as TG, being greatly
decreased (P= 0.001) in liver but increased in serum
(P= 0.018) of leptin-treated chicks. Moreover, the serum
content of ApoB significantly increased (P= 0.022) in
newly hatched chicks from the leptin-treated group.
Hepatic expression of genes involved in the regulation of
lipid metabolism
The hepatic expression of SREBP-1c (P=0.027), SREBP-2
(P=0.030), HMGCR (P =0.001) and CYP7A1 (P=0.041)
mRNA was significantly up-regulated in leptin-treated
chicks at hatching (Figure 2A). In agreement with theTable 4 Effects of in ovo leptin administration on leptin
concentration and lipid metabolic parameters in liver and
serum of newly hatched chicks
Parameter Control Leptin
Liver leptin (ng/g T-protein) 42.71 ± 4.06 58.06 ± 5.42*
TG (μmol/g liver) 23.15 ± 1.38 20.12 ± 0.54
Tch (μmol/g liver) 16.88 ± 0.62 13.80 ± 0.13**
Serum leptin (ng/mL) 1.10 ± 0.11 1.53 ± 0.10**
TG (mmol/L) 0.67 ± 0.06 0.90 ± 0.07*
Tch (mmol/L) 8.44 ± 0.22 9.93 ± 0.43*
ApoB (g/L) 0.096 ± 0.009 0.138 ± 0.017*
Values are represented as means ± SEM, *P< 0.05, **P< 0.01 compared with










































LEPR  (180 KDa)
Control Leptin
β-actin  (43 KDa) 
Figure 1 Effect of in ovo leptin administration on hepatic mRNA
and protein expression of LEPR in newly hatched chicks. A:
Immunoreactive bands for LEPR and β-actin protein; B: LEPR protein
content; C: LEPR mRNA. Values are presented as fold change relative
to the control, expressed as means ± SEM, n = 12.
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(P=0.032) and SREBP-2 (P=0.001) in liver were signifi-
cantly increased in leptin-treated chicks. However, thehepatic content of HMGCR and CYP7A1 protein was not
affected by in ovo leptin treatment (Figure 2B).
miRNA Quantification
Among the five miRNAs predicted to target SREBP-1c,
gga-miR-99a, gga-miR-100, gga-miR-200b and gga-miR-
429 were found to be significantly (P< 0.05) up-regulated
in the liver of leptin-treated chickens. Among the nine
miRNAs predicted to target HMGCR, the expression of
gga-miR-200a, gga-miR-200b and gga-miR-429 was signifi-
cantly increased (P< 0.05). It is worth noting that gga-
miR-200b and gga-miR-429 were predicted to target both
SREBP-1c and HMGCR (Table 5).
Discussion
Increasing evidence suggests that maternal leptin pro-
grams fetal growth and development in mammalian spe-
cies. In rats, dams receiving three injections of human
recombinant leptin (3.5 mg/kg, Intraperitoneal Injection,
i.p.) on days 8, 10 and 12 of gestation produced pups
with reduced birth weight [13]. Accordingly, in the
present study in ovo leptin administration reduced the
hatch weight of broiler chickens. This observation, how-
ever, contradicts a previous publication in which in ovo
injection of recombinant mouse leptin on day 5 of incu-
bation advanced hatching by 5 to 24 h and improved the
hatch weight of Japanese quails [15]. Perhaps the effect
of leptin on Japanese quails is different than its effect on
chickens. Furthermore, different doses of a hormone, like
leptin, usually have diverse physical effects. These factors
may contribute to the discrepancy in the results.
In ovo administration of leptin increased the propor-
tional liver weight in the leptin-treated chickens at
hatching. The increased liver index could be the conse-
quence of decreased body weight, yet it has been sug-
gested that alterations in proportional liver weight are
usually associated with the change in hepatic lipid metab-
olism in the chicken [38-40]. Our results support this no-
tion as the increased liver index correlated with alterations
in hepatic and serum TG and Tch concentrations in newly
hatched broiler chickens. Moreover, we observed, for the
first time, a positive correlation between liver weight
and hepatic leptin production and secretion in prenatally
leptin-exposed chickens, which is in agreement with a pre-
vious report showing that the liver weight positively corre-
lates with the plasma leptin concentrations in broiler
breeder hens [41].
To date, the mechanism by which maternal leptin
influences offspring leptin secretion has not been clari-
fied. A transplacental transfer of maternal leptin to the
fetus, which increases during late pregnancy in parallel
with an up-regulation of expression of the shorter isoforms
of the leptin receptor in the placenta, has been reported




























































Control   Leptin Control   Leptin Control   Leptin Control   Leptin 
A
B
Figure 2 Effects of in ovo leptin administration on hepatic expression of genes involved in lipid metabolism in newly hatched chicks.
A: mRNA; B: protein. Values are presented as fold change relative to the control, expressed as means ± SEM. *P< 0.05, **P< 0.01, n = 12.
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or transported to the developing embryos. We detected a
significant down-regulation of LEPR mRNA expression in
the yolk sac of leptin-treated embryos at 12 days of incu-
bation (data not shown). However, the physiologicalsignificance of this down-regulation remains elusive. It is
unlikely that the injected murine leptin remains active
over 21 days of incubation, thus the increased hepatic and
serum leptin contents in newly hatched chickens are most
likely the consequences of an altered developmental
Table 5 Effects of in ovo leptin administration on hepatic
expression of miRNAs predicted to target SREBP-1c and
HMGCR in newly hatched chicks
Target Genes miRNA Control Leptin P value
SREBP-1c gga-miR-99a 0.98 ± 0.11 2.11 ± 0.42 0.024
gga-miR-100 1.00 ± 0.11 2.03 ± 0.38 0.026
gga-miR-183 1.05 ± 0.23 1.70 ± 0.23 0.070
gga-miR-200b 0.97 ± 0.11 1.99 ± 0.40 0.033
gga-miR-429 1.05 ± 0.08 2.04 ± 0.40 0.038
HMGCR gga-miR-15a 1.02 ± 0.12 1.84 ± 0.41 0.086
gga-miR-15b 1.00 ± 0.10 1.24 ± 0.27 0.427
gga-miR-16 1.03 ± 0.11 1.62 ± 0.36 0.147
gga-miR-27b 1.02 ± 0.08 1.22 ± 0.23 0.416
gga-miR-181a 0.96 ± 0.08 1.00 ± 0.18 0.663
gga-miR-200a 1.02 ± 0.11 2.52 ± 0.64 0.045
gga-miR-200b 0.97 ± 0.11 1.99 ± 0.40 0.033
gga-miR-223 1.04 ± 0.07 1.39 ± 0.28 0.249
gga-miR-429 1.05 ± 0.08 2.04 ± 0.40 0.038
Values are presented as fold change relative to the control, expressed as
means ± SEM (n = 12).
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stage.
Leptin has been shown to exert direct effects on lipoly-
sis and lipogenesis of adipose tissue in mammalian spe-
cies [2]. Instead of the mammalian adipose tissue, liver is
the primary organ for lipid metabolism in the chicken
[17]. In the present study, the TG and Tch contents were
greatly decreased in the liver, but were significantly
increased in the serum of leptin-treated chickens, which
was accompanied by a trend of increase in serum ApoB
levels. ApoB is a major protein component of the plasma
very low-density and low-density lipoproteins (VLDL
and LDL, respectively) and plays an important role in
transporting cholesterol and triglycerides from the liver
[44]. The associated changes in serum ApoB and TG/
Tch may indicate enhanced TG and Tch transport from
the liver of leptin-treated chickens at hatching.
SREBPs directly activate the expression of more than
30 genes dedicated to cholesterol and fatty acid synthesis
in the liver [18]. In the present study, the mRNA expres-
sion and protein contents of SREBP-1c and SREBP-2
were both enhanced in the liver of leptin-treated chicks
at hatching. HMGCR and CYP7A1, which are dedicated
respectively to the synthesis and uptake of cholesterol,
were both significantly up-regulated in the liver of lep-
tin-treated chickens, indicating a positive transcriptional
regulation of SREBP-2 on HMGCR and CYP7A1 genes.
SREBP-1c and SREBP-2 share a mechanism of feedback
regulation, mediated by sterol response elements (SREs)
present in the enhancer/promoters of each gene. Accumu-
lation of hepatic TG and Tch has been reported to reduceSREBPs processing [18]. Therefore, the up-regulation of
hepatic SREBP-1c and SREBP-2 expression may be the
result of the reduced hepatic contents of TG and Tch in
leptin-treated chickens.
Leptin could interact with leptin receptor to imple-
ment its biological functions [45,46]. Although the serum
leptin concentration in the leptin-treated neonatal chicks
was significantly increased, no significant alterations
were detected in LEPR protein and mRNA expression in
liver. Chicken leptin has been reported to desensitize its
own response by decreasing the expression of its recep-
tor mRNA [46]. The lack of change in hepatic LEPR ex-
pression in leptin-treated chickens implies a possible
desensitizing effect of the elevated serum leptin on its re-
ceptor. In general, leptin plays an important role in the
negative regulation of lipogenesis in mammals [2]. In
contrast to its inhibitory effects on the expression of
SREBPs [2], HMGCR and CYP7A1 [19] in mammals,
in ovo leptin administration enhanced mRNA expression
of SREBP-1c/2, HMGCR and CYP7A1 in the present
study, in parallel with elevated serum leptin concentra-
tion. It is possible that the effect of leptin on the hepatic
expression of lipogenesis genes is species specific, being
stimulatory in poultry yet inhibitory in mammals. Taking
into consideration the irresponsiveness of hepatic LEPR,
another possibility is that the enhanced hepatic expres-
sion of SREBPs, HMGCR and CYP7A1 may not be the
direct effect of leptin. Other hormones or metabolites,
altered by in ovo leptin treatment, may participate in the
regulation of hepatic lipid metabolism and lipogenic
gene expression, as well as hepatic leptin production and
secretion.
Recently, considerable interest has been shown to-
wards the role of miRNA in the regulation of lipid me-
tabolism [23,24]. We detected concurrent changes in the
expression of miRNAs and their target genes, which
seems to contradict the common notion that the expres-
sion of miRNAs and their target genes are normally
negatively correlated. However, the functions of miRNAs
are much more complex and new mechanisms are emer-
ging. For instance, although miRNAs are known to pre-
dominantly act in translational repression, miR-10 has
been recently found to bind a group of transcripts con-
taining a terminal oligo-pyrimidine (TOP) motif and to
induce their translation [47]. Moreover, a time lag may
exist between the expression of miRNAs and the end-
point of their actions in destruction of mRNAs or trans-
lational repression of target genes. We observed the
uncoupling of HMGCR mRNA (up-regulated) and pro-
tein (unchanged) in the liver of leptin-treated chicks,
which coincided with significantly increased expression of
gga-miR-200a, gga-miR-200b and gga-miR-429 that were
predicted to target the chicken HMGCR gene. However,
further studies are required to clarify whether these
Hu et al. Journal of Animal Science and Biotechnology 2012, 3:16 Page 8 of 9
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protein content despite increased mRNA abundance.
In the present study, five out of 12 miRNAs predicted
to target SREBP-1c and/or HMGCR, were significantly
up-regulated in the liver of leptin-treated chicks. It is
noteworthy that gga-miR-99a and gga-miR-100 belong to
the miRNA gene family of miR-99, while the remaining
three miRNAs, gga-miR-200a, gga-miR-200b and gga-
miR-429, belong to the miRNA gene family of miR-8,
located in the same miRNA cluster. In agreement with
our results, it is presumed that miRNAs from the same
family share similar biological functions and miRNAs
from the same miRNA cluster normally have the same
expression pattern. However, further experiments are ne-
cessary to validate the function of these five miRNAs on
the expression of the target genes and hepatic lipid me-
tabolism in the chicken.
Conclusions
We have shown for the first time that in ovo administra-
tion of leptin decreases the hatch weight, and modifies
hepatic leptin synthesis and secretion, as well as hepatic
lipid metabolism in newly hatched broiler chickens. A
miRNA-mediated regulation of cholesterogenic and lipo-
genic genes, such as SREBPs and HMGCR, may be
involved in these effects.
Abbreviations
miRNAs: MicroRNAs; LEPR: Leptin receptor; TG: Triglyceride; Tch: Total
cholesterol; ApoB: Apolipoprotein B; SREBP-1c: Sterol regulator element
binding protein 1c; SREBP-2: Sterol regulator element binding protein 2;
HMGCR: Hydroxy-3-methylglutaryl coenzyme A reductase;
CYP7A1: Cholesterol 7α-hydroxylase 1; SREBPs: Sterol regulatory element
binding proteins; ACC: Acetyl CoA carboxylase; CPT-I: Carnitine
palmitoyltransferase I; FAS: Fatty acid synthase; PBS: Phosphate buffered
saline; SREs: Sterol response elements.
Competing interests
The authors declare that they have no competing interests.
Acknowledgements
This work was supported by the NSFC-Guangdong Joint Fund (U0931004),
the Sino-German Cooperation in Agriculture (Project No. 28/04-05CHN7,
2010-2011), the Special Fund for Agro-scientific Research in the Public
Interest (201003011), the National “948” project (2011-S11), the Natural
Science Foundation of Jiangsu Province (BK2010296), the Doctor Foundation
of the Institute of Poultry Science of Jiangsu Province (JQ201001) and the
Priority Academic Program Development of Jiangsu Higher Education
Institutions.
Author details
1Key Laboratory of Animal Physiology & Biochemistry, Nanjing Agricultural
University, Nanjing, 210095, China. 2Key Laboratory of Poultry Heredity &
Breeding, Institute of Poultry Science of Jiangsu Province, Yangzhou, 225003,
China. 3Department of Functional Genomics & Bioregulation, Institute of
Animal Science Mariensee, 31535, Neustadt, Germany.
Authors’ contributions
YH carried out the experiments, participated in the data collection, data
analysis and interpretation, and drafted the manuscript. RZ performed the
analysis of the hepatic microRNAs’ expression, helped in data interpretation
and paper drafting. YZ and JL performed the protein quantification by
western blot analysis. RG provided valuable advice for this study and helpedin editing the manuscript. RZ contributed in conception, experimental
design, data interpretation and finalized the manuscript. All authors
approved the final version of the manuscript for publication.
Received: 6 January 2012 Accepted: 11 May 2012
Published: 11 May 2012References
1. Harvey J, Ashford ML: Leptin in the CNS: much more than a satiety signal.
Neuropharmacology 2003, 44:845–854.
2. Muoio DM, Lynis DG: Peripheral metabolic actions of leptin. Best Pract Res
Clin Endocrinol Metab 2002, 16:653–666.
3. Friedman-Einat M, Boswell T, Horev G, Girishvarma G, Dunn IC, Talbot RT, et
al: The chicken leptin gene: has it been cloned? Gen Comp Endocrinol
1999, 115:354–363.
4. Hu Y, Ni Y, Ren L, Dai J, Zhao R: Leptin is involved in the effects of
cysteamine on egg laying of hens, characteristics of eggs, and posthatch
growth of broiler offspring. Poult Sci 2008, 87:1810–1817.
5. Neglia S, Arcamone N, Gargiulo G, de Girolamo P: Immunocytochemical
detection of leptin-like immunoreactivity in the chicken gastroenteric
tract. Gen Comp Endocrinol 2008, 155:432–437.
6. Ohkubo T, Nishio M, Tsurudome M, Ito M, Ito Y: Existence of leptin
receptor protein in chicken tissues: Isolation of a monoclonal antibody
against chicken leptin receptor. Gen Comp Endocrinol 2007, 151:269–273.
7. Denbow DM, Meade S, Robertson A, McMurtry JP, Richards M, Ashwell C:
Leptin-induced decrease in food intake in chickens. Physiol Behav 2000,
69(3):359–362.
8. Macajova M, Lamosova D, Zeman M: Role of Leptin in Japanese Quail
Development. Acta Vet 2002, 71:473–479.
9. Vickers MH: Developmental programming and adult obesity: the role of
leptin. Curr Opin Endocrinol Diabetes Obes 2007, 14:17–22.
10. McMillen IC, Edwards LJ, Duffield J, Muhlhausler BS: Regulation of leptin
synthesis and secretion before birth: implications for the early
programming of adult obesity. Reproduction 2006, 131:415–427.
11. Stocker C, O'Dowd J, Morton NM, Wargent E, Sennitt MV, Hislop D, et al:
Modulation of susceptibility to weight gain and insulin resistance in low
birthweight rats by treatment of their mothers with leptin during
pregnancy and lactation. Int J Obes Relat Metab Disord 2004, 28:129–136.
12. Yura S, Itoh H, Sagawa N, Yamamoto H, Masuzaki H, Nakao K, et al: Role of
premature leptin surge in obesity resulting from intrauterine
undernutrition. Cell Metab 2005, 1:371–378.
13. Nilsson C, Swolin-Eide D, Ohlsson C, Eriksson E, Ho HP, Bjorntorp P, et al:
Reductions in adipose tissue and skeletal growth in rat adult offspring
after prenatal leptin exposure. J Endocrinol 2003, 176:13–21.
14. Rao K, Xie J, Yang X, Chen L, Grossmann R, Zhao R: Maternal low-protein
diet programmes offspring growth in association with alterations in yolk
leptin deposition and gene expression in yolk-sac membrane,
hypothalamus and muscle of developing Langshan chicken embryos. Br
J Nutr 2009, 102:848–857.
15. Lamosova D, Macajova M, Zeman M, Mozes S, Jezova D: Effect of in ovo
leptin administration on the development of Japanese quail. Physiol Res
2003, 52:201–209.
16. Ashwell CM, Richards MP, McMurtry JP: The ontogeny of leptin mRNA
expression in growing broilers and its relationship to metabolic body
weight. Domest Anim Endocrinol 2001, 21:161–168.
17. Taouis M, Dridi S, Cassy S, Benomar Y, Raver N, Rideau N, et al: Chicken
leptin: properties and actions. Domest Anim Endocrinol 2001, 21:319–327.
18. Horton JD, Goldstein JL, Brown MS: SREBPs: activators of the complete
program of cholesterol and fatty acid synthesis in the liver. J Clin Invest
2002, 109:1125–1131.
19. Vanpatten S, Karkanias GB, Rossetti L, Cohen DE: Intracerebroventricular leptin
regulates hepatic cholesterol metabolism. Biochem J 2004, 379:229–233.
20. Zhao Y, Srivastava D: A developmental view of microRNA function. Trends
Biochem Sci 2007, 32:189–197.
21. Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ: MicroRNAs in lipid
metabolism. Curr Opin Lipidol 2011, 22:86–92.
22. Moore KJ, Rayner KJ, Suarez Y, Fernandez-Hernando C: microRNAs and
cholesterol metabolism. Trends Endocrinol Metab 2010, 21:699–706.
23. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, et al:
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol
homeostasis. Science 2010, 328:1566–1569.
Hu et al. Journal of Animal Science and Biotechnology 2012, 3:16 Page 9 of 9
http://www.jasbsci.com/content/3/1/1624. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, et al:
MiR-33 contributes to the regulation of cholesterol homeostasis. Science
2010, 328:1570–1573.
25. Takanabe R, Ono K, Abe Y, Takaya T, Horie T, Wada H, et al: Up-regulated
expression of microRNA-143 in association with obesity in adipose tissue
of mice fed high-fat diet. Biochem Biophys Res Commun 2008, 376:728–732.
26. Xie H, Lim B, Lodish HF: MicroRNAs induced during adipogenesis that
accelerate fat cell development are downregulated in obesity. Diabetes
2009, 58:1050–1057.
27. Shao P, Zhou H, Xiao ZD, He JH, Huang MB, Chen YQ, et al: Identification of
novel chicken microRNAs and analysis of their genomic organization.
Gene 2008, 418:34–40.
28. Xu H, Wang X, Du Z, Li N: Identification of microRNAs from different tissues
of chicken embryo and adult chicken. FEBS Lett 2006, 580:3610–3616.
29. Hicks JA, Tembhurne P, Liu HC: MicroRNA expression in chicken embryos.
Poult Sci 2008, 87:2335–2343.
30. Hicks JA, Trakooljul N, Liu HC: Discovery of chicken microRNAs associated
with lipogenesis and cell proliferation. Physiol Genomics 2010, 41:185–193.
31. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and
purification of total lipides from animal tissues. J Biol Chem 1957,
226:497–509.
32. Li Y, Yuan L, Yang X, Ni Y, Xia D, Barth S, et al: Effect of early feed
restriction on myofibre types and expression of growth-related genes in
the gastrocnemius muscle of crossbred broiler chickens. Br J Nutr 2007,
98:310–319.
33. Shi R, Chiang VL: Facile means for quantifying microRNA expression by
real-time PCR. Biotechniques 2005, 39:519–525.
34. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by
adenosines, indicates that thousands of human genes are microRNA
targets. Cell 2005, 120:15–20.
35. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP:
MicroRNA targeting specificity in mammals: determinants beyond seed
pairing. Mol Cell 2007, 27:91–105.
36. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mRNAs are
conserved targets of microRNAs. Genome Res 2009, 19:92–105.
37. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
2001, 25:402–408.
38. Chen J, Tang X, Zhang Y, Ma H, Zou S: Effects of maternal treatment of
dehydroepiandrosterone (DHEA) on serum lipid profile and hepatic lipid
metabolism-related gene expression in embryonic chickens. Comp
Biochem Physiol B Biochem Mol Biol 2010, 155:380–386.
39. Maurice DV, Bodine AB, Rehrer NJ: Metabolic effects of low aflatoxin B1
levels on broiler chicks. Appl Environ Microbiol 1983, 45:980–984.
40. Chen KL, Chi WT, Chu C, Chen RS, Chiou PW: Effect of caponization and
testosterone implantation on hepatic lipids and lipogenic enzymes in
male chickens. Poult Sci 2007, 86:1754–1759.
41. Bruggeman V, Onagbesan OM, Decuypere E: Body weight, fat content,
liver weight and plasma leptin concentrations in broiler breeder females
reared under ad libitum feeding, restricted feeding or combinations of
both until age of first egg. Br Poultry Sci 2000, 41:57–59.
42. Smith JT, Waddell BJ: Leptin receptor expression in the rat placenta:
changes in ob-ra, ob-rb, and ob-re with gestational age and suppression
by glucocorticoids. Biol Reprod 2002, 67:1204–1210.
43. Smith JT, Waddell BJ: Leptin distribution and metabolism in the pregnant
rat: transplacental leptin passage increases in late gestation but is
reduced by excess glucocorticoids. Endocrinology 2003, 144:3024–3030.
44. Kirchgessner TG, Heinzmann C, Svenson KL, Gordon DA, Nicosia M, Lebherz
HG, et al: Regulation of chicken apolipoprotein B: cloning, tissue
distribution, and estrogen induction of mRNA. Gene 1987, 59:241–251.
45. Tartaglia LA: The leptin receptor. J Biol Chem 1997, 272:6093–6096.
46. Cassy S, Derouet M, Crochet S, Dridi S, Taouis M: Leptin and insulin
downregulate leptin receptor gene expression in chicken-derived
leghorn male hepatoma cells. Poult Sci 2003, 82:1573–1579.
47. Lund AH: miR-10 in development and cancer. Cell Death Differ 2010,
17:209–214.
doi:10.1186/2049-1891-3-16
Cite this article as: Hu et al.: In ovo leptin administration affects hepatic
lipid metabolism and microRNA expression in newly hatched broiler
chickens. Journal of Animal Science and Biotechnology 2012 3:16.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
